Hispanic Accrual on Randomized Cancer Clinical Trials: a Call to Arms

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2014 May 21

PMID 24841978

Citations 14

Authors

Alberto Parra

Anand B Karnad

Ian M Thompson

Affiliations

Soon will be listed here.

Citing Articles

Navigating the challenges of clinical trial professionals in the healthcare sector.

Peralta G, Sanchez-Santiago B Front Med (Lausanne). 2024; 11:1400585.

PMID: 38887672 PMC: 11181308. DOI: 10.3389/fmed.2024.1400585.

Engaging Latinos in an Academic-Community Partnership in Montana through a Health Screening Event.

Moyce S, Sisson N, Thompson S, Velazqueaz M, Claudio D, Aghbashian E Am J Health Educ. 2021; 52(2):72-79.

PMID: 34900073 PMC: 8664255. DOI: 10.1080/19325037.2021.1877221.

Best practices for recruitment of adolescents for biobanking and precision health research: a retrospective analysis comparing juvenile idiopathic arthritis cases with healthy controls.

Lewis K, Brooks S, Carrasco R, Carter P, Garcia A, Chiou J Pediatr Rheumatol Online J. 2021; 19(1):169.

PMID: 34863185 PMC: 8645089. DOI: 10.1186/s12969-021-00652-9.

Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.

duPont N, Enserro D, Brady M, Moxley K, Walker J, Cosgrove C Gynecol Oncol. 2021; 164(2):398-405.

PMID: 34857397 PMC: 9400113. DOI: 10.1016/j.ygyno.2021.11.013.

Knowledge, Motivations and Concerns about Participation in Breast Cancer Clinical Trials in Puerto Rico.

Rivera-Diaz M, Garcia-Romero A, Ayala-Marin A, Velez-Alamo C, Acevedo-Fontanez A, Arevalo M J Health Dispar Res Pract. 2021; 13(1):50-66.

PMID: 34221702 PMC: 8248579.

References

Sosman J, Kim K, Schuchter L, Gonzalez R, Pavlick A, Weber J . Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012; 366(8):707-14. PMC: 3724515. DOI: 10.1056/NEJMoa1112302. View

Karlan B, Oza A, Richardson G, Provencher D, Hansen V, Buck M . Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. J Clin Oncol. 2011; 30(4):362-71. DOI: 10.1200/JCO.2010.34.3178. View

Socinski M, Bondarenko I, Karaseva N, Makhson A, Vynnychenko I, Okamoto I . Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol. 2012; 30(17):2055-62. DOI: 10.1200/JCO.2011.39.5848. View

Cruciani R, Zhang J, Manola J, Cella D, Ansari B, Fisch M . L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012; 30(31):3864-9. PMC: 3478577. DOI: 10.1200/JCO.2011.40.2180. View

Kindler H, Karrison T, Gandara D, Lu C, Krug L, Stevenson J . Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol. 2012; 30(20):2509-15. PMC: 3397785. DOI: 10.1200/JCO.2011.41.5869. View

Trevino M, Padalecki S, Karnad A, Parra A, Weitman S, Nashawati M . The Development of a Minority Recruitment Plan for Cancer Clinical Trials. J Community Med Health Educ. 2014; 3(5):1000230. PMC: 4141778. DOI: 10.4172/2161-0711.1000230. View

Scagliotti G, Vynnychenko I, Park K, Ichinose Y, Kubota K, Blackhall F . International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1. J Clin Oncol. 2012; 30(23):2829-36. DOI: 10.1200/JCO.2011.41.4987. View

OBrien S, Schiller G, Lister J, Damon L, Goldberg S, Aulitzky W . High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. J Clin Oncol. 2012; 31(6):676-83. PMC: 4979201. DOI: 10.1200/JCO.2012.46.2309. View

Kim E, Carrigan T, Menon V . Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol. 2008; 52(8):672-3. DOI: 10.1016/j.jacc.2008.05.025. View

10.

Lynch T, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R . Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol. 2012; 30(17):2046-54. DOI: 10.1200/JCO.2011.38.4032. View

11.

Uldrick T, Wyvill K, Kumar P, OMahony D, Bernstein W, Aleman K . Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol. 2012; 30(13):1476-83. PMC: 3383119. DOI: 10.1200/JCO.2011.39.6853. View

12.

Levine A, Noy A, Lee J, Tam W, Ramos J, Henry D . Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2012; 31(1):58-64. PMC: 3530691. DOI: 10.1200/JCO.2012.42.4648. View

13.

Kim E, Menon V . Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol. 2009; 29(3):279-83. DOI: 10.1161/ATVBAHA.108.179796. View

14.

Paz-Ares L, Biesma B, Heigener D, von Pawel J, Eisen T, Bennouna J . Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer. J Clin Oncol. 2012; 30(25):3084-92. DOI: 10.1200/JCO.2011.39.7646. View

15.

Tap W, Demetri G, Barnette P, Desai J, Kavan P, Tozer R . Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors. J Clin Oncol. 2012; 30(15):1849-56. DOI: 10.1200/JCO.2011.37.2359. View

16.

Siegel R, Naishadham D, Jemal A . Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin. 2012; 62(5):283-98. DOI: 10.3322/caac.21153. View

17.

Unger J, Hershman D, Albain K, Moinpour C, Petersen J, Burg K . Patient income level and cancer clinical trial participation. J Clin Oncol. 2013; 31(5):536-42. PMC: 3565180. DOI: 10.1200/JCO.2012.45.4553. View

18.

Haile R, John E, Levine A, Cortessis V, Unger J, Gonzales M . A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila). 2012; 5(2):150-63. PMC: 5815320. DOI: 10.1158/1940-6207.CAPR-11-0447. View

19.

Levenback C, Ali S, Coleman R, Gold M, Fowler J, Judson P . Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012; 30(31):3786-91. PMC: 3478573. DOI: 10.1200/JCO.2011.41.2528. View

20.

Unger J, Coltman Jr C, Crowley J, Hutchins L, Martino S, Livingston R . Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2005; 24(1):141-4. DOI: 10.1200/JCO.2005.02.8928. View